Literature DB >> 27158332

Nerve distribution of canine pulmonary arteries and potential clinical implications.

Yun Zhang1, Weijie Chen1, Yanping Xu1, Hang Liu1, Yunlin Chen1, Hanxuan Yang1, Yuehui Yin2.   

Abstract

Sympathetic activation plays an important pathophysiological role in the progression of pulmonary artery hypertension. Although adrenergic vasomotor fibers are present in the adventitia of pulmonary arteries, the anatomy of the peri-arterial pulmonary nerves is still poorly understood. The aim of the current study was to determine the sympathetic nerve distribution in canine pulmonary arteries. A total of 2160 sympathetic nerves were identified in six Chinese Kunming canines. Nerve counts were greatest in the proximal segment, with a slight decrease in the distal segment; the middle segment showed the least number of nerves. In the left and right pulmonary arteries, 77.61% and 78.97% of the nerves were located within a 1-3-mm range, respectively. The number of nerves in the posterior region of the bifurcation and pulmonary trunk outnumbered those in the anterior region. Furthermore, 65.33% of the nerves were located in the first 2-mm range of the posterior region of bifurcation, and 89.62% of the nerves were located within the 1-3-mm range of the posterior region of the pulmonary trunk. In conclusion, a great abundance of sympathetic nerves occurred in the proximal and distal segments of the bilateral pulmonary arteries. There is a clear predominance of sympathetic nerve distribution in the posterior region of the bifurcation and pulmonary trunk. This anatomic distribution may have implications for the future development of percutaneous pulmonary artery denervation.

Entities:  

Keywords:  Bifurcation of the pulmonary trunk; percutaneous pulmonary artery denervation; pulmonary artery; pulmonary trunk; sympathetic

Year:  2016        PMID: 27158332      PMCID: PMC4846889     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  18 in total

1.  Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension.

Authors:  Agnieszka Ciarka; Vi Doan; Sonia Velez-Roa; Robert Naeije; Philippe van de Borne
Journal:  Am J Respir Crit Care Med       Date:  2010-03-01       Impact factor: 21.405

2.  Atrial septostomy decreases sympathetic overactivity in pulmonary arterial hypertension.

Authors:  Agnieszka Ciarka; Jean-Luc Vachièry; Anne Houssière; Marko Gujic; Eric Stoupel; Sonia Velez-Roa; Robert Naeije; Philippe van de Borne
Journal:  Chest       Date:  2007-03-30       Impact factor: 9.410

3.  Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension.

Authors:  Frances S de Man; M Louis Handoko; Joris J M van Ballegoij; Ingrid Schalij; Sylvia J P Bogaards; Pieter E Postmus; Jolanda van der Velden; Nico Westerhof; Walter J Paulus; Anton Vonk-Noordegraaf
Journal:  Circ Heart Fail       Date:  2011-12-09       Impact factor: 8.790

4.  Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).

Authors:  Shao-Liang Chen; Feng-Fu Zhang; Jing Xu; Du-Jiang Xie; Ling Zhou; Thach Nguyen; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

5.  Tyrosine hydroxylase immunoreactivity as indicator of sympathetic activity: simultaneous evaluation in different tissues of hypertensive rats.

Authors:  Katia Burgi; Marina T Cavalleri; Adilson S Alves; Luiz R G Britto; Vagner R Antunes; Lisete C Michelini
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-09       Impact factor: 3.619

6.  Increased sympathetic nerve activity in pulmonary artery hypertension.

Authors:  Sonia Velez-Roa; Agnieszka Ciarka; Boutaina Najem; Jean-Luc Vachiery; Robert Naeije; Philippe van de Borne
Journal:  Circulation       Date:  2004-08-30       Impact factor: 29.690

7.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

Review 8.  Future perspectives for the treatment of pulmonary arterial hypertension.

Authors:  Hossein A Ghofrani; Robyn J Barst; Raymond L Benza; Hunter C Champion; Karen A Fagan; Friedrich Grimminger; Marc Humbert; Gérald Simonneau; Duncan J Stewart; Carlo Ventura; Lewis J Rubin
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

9.  Effects of basic fibroblast growth factor and cyclin D1 on cigarette smoke-induced pulmonary vascular remodeling in rats.

Authors:  Sijing Zhou; Min Li; Daxiong Zeng; Gengyun Sun; Junsheng Zhou; Ran Wang
Journal:  Exp Ther Med       Date:  2014-10-31       Impact factor: 2.447

10.  Neurofilaments are obligate heteropolymers in vivo.

Authors:  M K Lee; Z Xu; P C Wong; D W Cleveland
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

View more
  3 in total

Review 1.  Pulmonary Artery Denervation: Update on Clinical Studies.

Authors:  Hang Zhang; Shao-Liang Chen
Journal:  Curr Cardiol Rep       Date:  2019-09-05       Impact factor: 2.931

Review 2.  The progress of pulmonary artery denervation.

Authors:  Yonghui Xie; Na Liu; Zhenghui Xiao; Fang Yang; Yunhong Zeng; Zhou Yang; Yuanxi Xia; Zhi Chen; Yunbin Xiao
Journal:  Cardiol J       Date:  2021-01-13       Impact factor: 3.487

Review 3.  Current status of pulmonary artery denervation.

Authors:  Mark G Davies; Dimitrios Miserlis; Joseph P Hart
Journal:  Front Cardiovasc Med       Date:  2022-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.